The Hidden Differences Between Oral Contraceptives
National adverse-event and prescribing data suggest oral contraceptive formulations differ in reported acne, migraine, anxiety, and depression
-
By
-
Henry Thomas
-
March 26, 2026
-
Clinical Scorecard: The Hidden Differences Between Oral Contraceptives
At a Glance
| Category | Detail |
|---|
| Condition | Oral contraceptive side effects |
| Key Mechanisms | Variations in progestin components and pharmacologic properties across formulations |
| Target Population | Women using oral contraceptives |
| Care Setting | Outpatient, primary care, and gynecology |
Key Highlights
- Higher rates of acne reported with drospirenone, levonorgestrel, and norgestimate formulations
- Drospirenone linked to increased rates of migraine and depression
- Anxiety reports varied, with higher rates in levonorgestrel and desogestrel users
- Norethindrone-only pills associated with lower anxiety rates
- Overall low depression rates across most formulations
Guideline-Based Recommendations
Diagnosis
- Monitor for dermatologic and mood-related symptoms in patients using oral contraceptives
Management
- Consider formulation-specific side-effect profiles when prescribing oral contraceptives
Monitoring & Follow-up
- Assess patient-reported side effects regularly, particularly for acne, migraine, anxiety, and depression
Risks
- Be aware of potential increased side effects associated with specific progestin formulations
Patient & Prescribing Data
Women of reproductive age using oral contraceptives
Formulation choice may need to be tailored based on individual patient health conditions and side effect profiles
Clinical Best Practices
- Utilize adverse-event reporting data to inform contraceptive choices
- Engage in shared decision-making with patients regarding contraceptive options
- Educate patients on potential side effects associated with different formulations
References
